Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 41Prostatic Neoplasms 32Ovarian Neoplasms 23Testicular Neoplasms 18Carcinoma, Transitional Cell 16Carcinoma, Renal Cell 16Carcinoma, Non-Small-Cell Lung 15Neoplasms 13Melanoma 13Testicular Germ Cell Tumor 12Colorectal Neoplasms 12Breast Neoplasms 12Neoplasm Metastasis 10Urethral Neoplasms 9Stomach Neoplasms 9Lung Neoplasms 9Endodermal Sinus Tumor 9Teratoma 8Pancreatic Neoplasms 8Central Nervous System Neoplasms 8Carcinoma, Embryonal 8Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Seminoma 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Penile Neoplasms 4

Interventions

Gemcitabine 30Mitomycin 25BCG Vaccine 13Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5dodecyl maltoside 5Radiotherapy 5Cystoscopy 5apaziquone 4ALT-803 4tislelizumab 35-aminolevulinic acid hexyl ester 3viscum album peptide 2pembrolizumab 2disitamab vedotin 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 2Administration, Intravesical 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Paclitaxel × Genitourinary × Clear all
NCT06173349 2026-03-13

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

University of California, Davis

Phase 1 Recruiting
12 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡